The TAVR procedure will be performed in the new Hybrid OR at St. Luke’s by cardiothoracic surgeon Stephen Olenchock, DO, Section Chief, Cardiovascular Surgery, St. Luke’s University Health Network. This leading-edge procedure is approved for patients who are not candidates for open heart surgery procedures, because the risk of an open heart procedure would be too great. Earlier this year, St. Luke’s became one of the first institutions in the country to offer TAVR with the Edwards Sapien valve due to exceptional outcomes and a multidisciplinary team approach.TAVR is an alternative to open heart surgery for valve replacement in which a catheter is guided through a small incision in the groin and then advanced through the femoral artery. The valve is deployed via catheter. TAVR received FDA approved in November 2011. This procedure is approved for patients who are not candidates for open heart surgery procedures, because the risk of an open heart procedure would be too great. To qualify for TAVR, patients cannot have severe buildup of plaque in the arteries.
St. Luke’s University Hospital Is First In The United States To Install GE Healthcare’s Discovery IGS 730 Hybrid Operating Room
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts